Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03541642 · ClinicalTrials.gov registry record · NA

PrEP Communication Intervention for Female Clients of a Needle Exchange

A NA study, sponsored by Temple University.

Completed
Registry status
NA
Development phase
35
Enrollment target

NCT03541642 is a NA study that has completed, run by Temple University. The registered enrollment target is 35 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03541642, a NA study, has completed, sponsored by Temple University.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

This study will identify perceptions of PrEP in women who inject drugs (WWIDs) and develop and pilot test a targeted intervention that will be embedded in a large, urban syringe exchange program through an extensive formative evaluation process. Using perceptual mapping, an innovative marketing evaluation technique, WWIDs' PrEP perceptions will be incorporated into messaging in targeted counseling, materials, and text messaging to encourage PrEP adherence. This will then be tested in a pilot Randomized Controlled Trial (RCT) by comparing it to a general PrEP intervention to assess for uptake and adherence to PrEP, as well as improved self-efficacy and lower decisional conflict.

Interventions

  • BEHAVIORAL Enhanced Intervention
  • BEHAVIORAL Basic Intervention

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2018-06-01
Est. Completion 2021-12-17
Phase NA

Sponsor

Temple University

163 total trials

What the Registry Record Tells You About NCT03541642

The ClinicalTrials.gov registry entry for NCT03541642 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Enhanced Intervention is the first listed.

NCT03541642 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03541642 about?

NCT03541642 is a clinical study titled "PrEP Communication Intervention for Female Clients of a Needle Exchange". This study will identify perceptions of PrEP in women who inject drugs (WWIDs) and develop and pilot test a targeted intervention that will be embedded in a large, urban syringe exchange program through an extensive formative evaluation process. Using perceptual mapping, an innovative marketing eval...

What is the current status of trial NCT03541642?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2018-06-01. Estimated completion is 2021-12-17.

What interventions are being tested in trial NCT03541642?

The interventions under investigation include: Enhanced Intervention (BEHAVIORAL), Basic Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03541642?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.